Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism
Authors:
- Dieter NaberDNDieter Naber
- Martin LambertMLMartin Lambert
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 28 (8) , 1213-1219
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophreniaInternational Journal of Neuropsychopharmacology, 2003
- Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic SchizophreniaThe Journal of Clinical Psychiatry, 2003
- Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective DisorderArchives of General Psychiatry, 2003
- Chlorpromazine Equivalent Doses for the Newer Atypical AntipsychoticsThe Journal of Clinical Psychiatry, 2003
- Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized studyPsychopharmacology, 2003
- Neurocognitive effects: aripiprazole vs olanzapine in stable psychosisEuropean Psychiatry, 2002
- Psychosocial outcomes in patients with schizophrenia: quality of life and reintegrationCurrent Opinion in Psychiatry, 2002
- Good tolerability equals good results: the patient’s perspectiveEuropean Neuropsychopharmacology, 2001
- Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugsSchizophrenia Research, 2001
- Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical FindingsSchizophrenia Bulletin, 1997